Kodiak Sciences closes $184M public offering of common stock with underwriters' full option exercise.
In Palo Alto, California on December 18, 2025, Kodiak Sciences Inc. (Nasdaq: KOD), a biotech company focused on retinal treatments, has completed the planned closing of a recent business initiative. The company is dedicated to pioneering innovative therapies for eye diseases.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments